Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Xoma expands pivotal Neuprex trials

Jan. 15, 1997

Antifungal agent described by Roussel Morishita

Jan. 15, 1997

FDA to review AmBisome NDA

Jan. 14, 1997

More oxazolidinone antimicrobial agents under study at P&U

Jan. 14, 1997

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

The Liposome Company's Abelcet receives marketing approval in 14th country

Jan. 13, 1997

Sequus' Amphotec earns 19th marketing approval

Jan. 10, 1997

Merck & Co. describes avermectin analogue

Jan. 10, 1997

Gilead files NDA for new cidofovir formulation

Jan. 7, 1997

Fujisawa reveals antibacterial series

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...